Columbia Global Centers | Mumbai, in partnership with Columbia Global Centers | Nairobi, hosted a panel discussion where distinguished experts discussed the current status of TB and MDR-TB globally and in India and Kenya.  They also explored why TB remains a leading health security threat, and suggested strategies for improving diagnostic capacity, guaranteeing high-quality treatment, and preventing transmission of this deadly disease.  As TB is an airborne infection like the SARS CoV-2 virus, the program addressed the co-existence and interaction of the two, including the effect of the pandemic on healthcare and efforts to eliminate TB, the implications of vaccines on both, and treatment outcomes.